Interstim

Renaming this division "Turnover" could boost sales.

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

wtf is interstim micro? and why would a smaller version of interstim take three years?

It's a 3cc microstimulator and allows MRI anywhere in the body. Marketing told us it won't hit the market until after 2020 so you do the math. I'm being conservative in my guess.

post

Just wait until Interstim Micro comes out...in 3 years.

wtf is interstim micro? and why would a smaller version of interstim take three years?

post

I agree it’s a superior system, but they’ve implanted less than 200 of these? Can they commercialize it and manufacture it at volume?

If they can supply it, they will have no problem selling it.

Just wait until Interstim Micro comes out...in 3 years.

post

Axonics has a far superiorly designed platform to anyone out here, including Interstim. This is going be like taking candy from a baby for them

I agree it’s a superior system, but they’ve implanted less than 200 of these? Can they commercialize it and manufacture it at volume?

If they can supply it, they will have no problem selling it.

post

You haven't heard of a non-compete?

Product also needs to be approved and commercialized before it can be sold.

You kind of answered your own question in the second sentence. Assuming there are even non-competes in place, Axonics will likely start building out their initial sales team prior to approval and commercialization as those reps won't be actively selling during that time. This gives Axonics time for the reps to finish out their non-competes, which are usually no more than one year. In fact, they will probably time the commercialization to start right when all of those initial reps come off the non-compete.

post

You haven't heard of a non-compete?

Product also needs to be approved and commercialized before it can be sold.

Axonics has a far superiorly designed platform to anyone out here, including Interstim. This is going be like taking candy from a baby for them

post

The only solid reps will be at Axonics very soon.

You haven't heard of a non-compete?

Product also needs to be approved and commercialized before it can be sold.

post

KK should do it. He can relate to the patients better than us young bucks.

The only solid reps will be at Axonics very soon.

post

This position makes me feel dirty. Not cool having to sell patients and manipulate them.

I love talking to 65 year old fat women about their peeing habits. What's wrong with you?

KK should do it. He can relate to the patients better than us young bucks.

post

At least there is fresh blood in the field monthly. The turnover rate is almost comical.

post

This division needs some fresh blood in sales management. Not sure how much longer I can listen to the same ideas over and over.

post

This position makes me feel dirty. Not cool having to sell patients and manipulate them.

I love talking to 65 year old fat women about their peeing habits. What's wrong with you?

post

This position makes me feel dirty. Not cool having to sell patients and manipulate them.

post

Think again

Maybe in 2027 when you come out with something that can compete.

post

My territory is rolling this year and we are seeing some nice growth, anywhere from 5-10% which is great for device. STJ and BSC are wasting away.

post

Loading...


Load More

Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.